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The objective of this study was to verify the potential hypoglycaemic property of 
Anacardium occidentale L. vein and leaf aqueous extract in type 2 diabetic rat 
model. The rats were treated with the extracts (5, 50, and 500 mg/kg), which were 
incorporated into the drinking water and given daily for 6 weeks. Oral glucose 
tolerance test (OGlT) with 1.5 g/kg of glucose challenge was then performed to 
monitor the serum glucose level. An additional dose of their respective treatment 
was given again orally during OGTT to enhance the effect. The results did not show 
any improvement in the glucose tolerance even after 6 weeks of treatment, except 
for the positive control~lybenclamide. However, the serum glucose level rate of 
increase after oral loading with glucose was suppressed in the group treated with 500 
m a g  of the leaf extract. Glucose uptake into the blood was delayed by 46.81%, 
33.02%, and 42.01% after 1, 3, and 6 weeks of treatment compared to before 
treatment. The same but milder effect was also seen in the 500 m a g  of the vein- 
treated group. 
The extract may have affected glucose absorption in the gastrointestinal tract. 
Therefore, another study was conducted to determine whether the extract has any 
significant effect on intestinal glucose absorption. In situ absorption technique 
according to Doluisio et al. (1969) was carried out. Kreb-Ringer phosphate buffer 
(KRPB) containing 7.5 mM glucose with or without the addition of A. occidentale 
L. leaf extract (1,5, 10, and 15 mg/ml) was then introduced into the lumen. Luminal 
samples were collected at various time intervals for glucose determination by GOD- 
PAP-method. 0.5 mM phlorizin was used as the positive control. The results showed 
that 10 mglml of the leaf extract inhibited glucose absorption in the jejunal segment 
of the experimental rats. Luminal glucose concentration was significantly higher at 
5, 10, and 20 minutes than the control (95.32% vs. 68.91%, 79.71% vs. 45.97%, and 
49.38% vs. 20.76% respectively), indicating less glucose was being absorbed. 
Nonetheless, the effect of 10 mg/ml could not beat the inhibition portrayed by 
phlorizin. 
At the same time, the leaf extract was also found to be able to interact with the 
standard blood glucose measurement [GOD-PAP-method], causing the measured 
value to be lower than the actual concentration. GOD-PAP-method is based on a 
simple oxidation reaction while the leaf extract was found to have high reducing 
power. The high reducing power of the leaf extract was believed to have 
counteracted the normal process of GOG-PAP-method, causing the values to be 
under-read. Nevertheless, the advantage of an extract with high reducing power is 
one could also be a good antioxidant. 
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Thus, this study suggests that the aqueous leaf extract of A. occidentale L. might 
contain chemicals for treating diabetes mellitus by inhibiting intestinal glucose 
absorption. It may also exhibit antioxidant activity in biological system because of 
its high reducing power. This will be a good supporting therapy for diabetes as 
antioxidant has beneficial effects on glycaemic control and may help to ameliorate 
diabetes complications. 
Abstrak tesis yang dikemukakan kepada Senat Universiti Putra Malaysia sebagai 
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Kajian ini dijalankan untuk menentukan keberkesanan ekstrak akues urat daun dan 
daun Anacardium occidentale L. dalam menurunkan kandungan aras glukosa serum 
darah pada model tikus diabetes jenis 2. Rawatan ekstrak urat daun dan daun A. 
occidentale L. (5, 50, dan 500 mg/kg) dicarnpurkan dalam air minuman dan 
diberikan setiap hari kepada tikus diabetik selama enam minggu. Ujian toleransi 
glukosa secara oral dengan "cabaran glukosa" sebanyak 1.5 g/kg dijalankan untuk 
menentukan kesan ekstrak terhadap kandungan glukosa serum darah. Pada masa 
yang sama, dos tambahan berdasarkan rawatan masing-masing diberikan secara oral 
untuk menambahkan kesan ekstrak tersebut. Malangnya, tiada sebarang dos rawatan 
yang berupaya merendahkan aras glukosa serum darah tikus diabetik walaupun 
setelah dirawat selama enam minggu, kecuali kumpulan kawalan positif iaitu 
glibenclamide. Walau bagaimanapun, terdapat perencatan pada kadar peningkatan 
aras glukosa serum darah setelah diberi "cabaran glukosa" secara oral pada 
kumpulan yang dirawat dengan 500 mg/kg ekstrak daun. Kadar peningkatan glukosa 
menurun sebanyak 46.81%, 33.02%, and 42.01% selepas dirawat selama 1, 3, dan 6 
minggu berbanding dengan sebelum rawatan. Kesan yang sama turut diperhatikan 
pada kumpulan yang dirawat dengan 500 mgkg  ekstrak urat daun tetapi kesannya 
adalah lebih lemah. 
Ini mungkin disebabkan ekstrak akues tersebut telah mengganggu penyerapan 
glukosa pada salur gastrousus. Oleh itu, satu lagi kajian telah dijalankan untuk 
menentukan sama ada ekstrak daun itu mempunyai kesan yang bererti terhadap 
kadar penyerapan glukosa pada usus. Teknik penyerapan in situ berdasarkan kaedah 
yang dikemukakan oleh Doluisio et al. (1969) telah dilakukan. Larutan penimbal 
fosfat Kreb-Ringer (KRPB) yang mengandungi 7.5 mM glukosa yang ditambah 
dengan ekstrak daun (1, 5, 10, dan 15 mglml) atau tanpa ekstrak dimasukkan ke 
dalam lumen dan disampel pada masa-masa tertentu. Sampel diuji dengan kaedah 
GOD-PAP untuk menentukan kandungan glukosa pada lumen. 0.5 mM phlorizin 
digunakan sebagai kawalan positif. Keputusan menunjukkan bahawa ekstrak daun 
pada kepekatan 10 mg/ml berupaya merencatkan penyerapan glukosa pada bahagian 
jejunum. Kandungan glukosa dalam lumen adalah lebih tinggi secara bererti pada 
minit ke-5, 10, dan 20 berbanding dengan kawalan (95.32% vs. 68.91%, 79.71% vs. 
45.97%, and 49.38% vs. 20.76% masing-masing). Ini menunjukkan kurang glukosa 
yang diserap. Walau bagaimanapun, kesan ekstrak pada kepekatan 10 mg/ml tidak 
dapat menandingi kesan yang ditunjukkan oleh phlorizin. 
Pada masa yang sama, ekstrak daun juga didapati berupaya bertindak balas dengan 
kaedah GOD-PAP yang digunakan untuk mengukur kepekatan glukosa darah. Ini 
menyebabkan nilai bacaan adalah lebih rendah daripada yang sebenarnya. Prinsip 
kaedah GOD-PAP adalah berdasarkan pada tindak balas pengoksidaan. Ekstrak 
daun pula didapati mempunyai kuasa penurunan yang tinggi. Kuasa penurunan 
ekstrak daun ini disyaki telah menghalang tindak balas asal GOD-PAP yang 
menyebabkan bacaannya menjadi lebih rendah daripada yang sebenarnya. Walaupun 
begitu, sesuatu ekstrak yang mempunyai kuasa penurunan yang tinggi juga 
berkemungkinan merupakan bahan antioksida yang baik. 
Oleh itu, keputusan kajian ini menunjukkan bahawa ekstrak akues daun A. 
occidentale L. mungkin mengandungi bahan kimia untuk merawat diabetes mellitus 
dengan merencatkan kadar penyerapan glukosa pada usus. Ekstrak daun juga 
mungkin mempunyai kesan antioksida pada sistem biologi kerana kuasa 
penurunannya yang tinggi. Kesan antioksida ini boleh dijadikan rawatan tambahan 
untuk diabetes kerana bahan antioksida adalah baik dalarn mengawal nilai glisemia 
dan komplikasi diabetes. 
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CHAPTER I 
INTRODUCTION 
Diabetes Mellitus-Disease of the 21St Century 
Diabetes mellitus rank sixth in 1999 as the leading cause of death in the United 
States (U.S.)--after heart disease, cancer, stroke, chronic respiratory disease, and 
unintentional injuries (Hoyert et al., 2001). Diabetes has been described since 
antiquity. It has been with us for over 3500 years and it is still with us today, without 
any ultimate cure. Every day, thousands of diabetes sufferers die of this disease and 
its complications. Death by diabetes was estimated to account to 810,000 in the year 
2000 (in WHO regions), 1.5% of the total deaths (World Health Organization, 
2001). 
Diabetes is not contagious, yet it is probably the world's fastest growing metabolic 
disease. It usually leads to other complications such as long-term damage, 
dysfunction, and failure of various organs e.g. blindness, renal failure, heart disease, 
high blood pressure, neuropathy, gangrene, infection, and foot disease that 
frequently leads to amputation (Montgomery, 1975; Kloppel et al., 1998; World 
Health Organization, 1998a). In U.S., the mortality rate of diabetes had increased 
3.3% causing it to jump from the seventh rank in 1998 to the sixth in 1999 as the 
leading cause of death (Hoyert et al., 2001). 
In the developing countries, life expectancy may be halved, where the prevalence is 
increasing and adequate treatment is often unavailable (King et al., 1993). The 
prevalence of diabetes in adults worldwide was estimated to be 4% (135 million) in 
1995. This figure is expected to project to 5.4% (300 million) by the year 2025. 
Although prevalence is higher in the developed countries than in the developing 
countries (6% and 3.3% in 1995 respectively) and will remain so in 2025 (7.6% and 
4.9% respectively), but the proportional increase is higher in the developing 
countries. There will be only 42% increase (from 51 to 72 million) in the developed 
countries but a 170% rise (from 84 to 228 million) is expected in the developing 
countries. Hence, more than 75% people with diabetes will reside in the developing 
countries in 2025 compared to only 62% in 1995 (King et al., 1998). 
Diabetes is not in the list of the top ten principal causes of deaths in the government 
hospitals of Malaysia (Ministry of Health, Malaysia, 1999a & 2000). Nevertheless, 
it is still a problem faced by many Malaysians. In Peninsular Malaysia alone, the 
prevalence was reported to increase approximately 2.5% within 10 yea re f rom 
6.3% in 1986 to 8.8% in 1996. The prevalence for the whole of Malaysia in 1996 
(inclusive of Sabah and Sarawak) was reported to be 8.3%. By estimating the total 
population of Malaysia to be approximately 21 million in 1996, Malaysia was 
homed to over 1.7 million sufferers. With longevity and further industrialisation, the 
number of people affected with diabetes may double by the year 2010 (Rugayah et 
al., 1999). 
Furthermore, the number of admission to government hospitals in Peninsular 
Malaysia for diabetes increased from 19,503 cases in 1990 to 25,125 cases in 1997, 
which is about 30% increment over the span of 7 years. Mortality due to diabetes 
also increased from 231 deaths in 1990 to 386 death in 1997, an increment of 
approximately 70% (Ministry of Health, Malaysia, 1999b). 
Diabetes is recognised worldwide as an important community health problem 
because it has significant impact on health, quality of life, and life expectancy of 
individuals, as well as on the health-care system. The economic burden of this 
disease is enormous. As a major non-communicable disease, diabetes mellitus alone 
claimed on the average around 8% of total health budgets in developed countries 
(World Health Organization, 1998b). 
Economic analyses performed in the 1980s suggested that the total (direct and 
indirect) economic costs associated with diabetes in the U.S. were between $13.7 
and $20.4 billion in the 1980s-era dollars. After adjusting to the 1990 dollars using 
the Consumer Price Index-U Inflater, the values were estimated between $17.2 and 
$28.2 billion (Javitt & Chiang, 1995). A more recent study by Ray et al. (1993) 
estimated the total cost of diabetes in 1992 to be $91.8 billion ($45.2 billion for 
direct costs and $46.4 billion for indirect costs)--four times of the previous 
estimates, even after adjusting for inflation (cited in Javitt & Chiang, 1995). In 
another study, the total direct medical care costs for people confirmed diabetes was 
$85.7 billion or 11.9% of U.S. health care expenditures in 1992 (Rubin et al., 1994). 
Meanwhile, American Diabetes Association (1998) estimated that $44.1 billion was 
attributed for direct medical expenditures and $54.1 billion for indirect costs, 
totalling up to approximately $98 billion for 1997. The full burden and exact cost of 
this disease is not easy to measure, as there are many hidden costs associated such as 
loss of human lives and abilities that transcends numerical measurement. Whatever 
the real cost may be, one thing for sure is that the economic burden of diabetes 
mellitus is immense. 
Therapy and Management of Diabetes 
Diagnosing diabetes was never a problem. According to ancient Hindu writings 
dated 1500 B.C., ants and insects were attracted to the urine of some people 
associated with a mysterious emaciating disease (Gordon, 1959; MacCracken & 
Hoel, 1997). But for thousand of years, no one knew how to live with it, let alone 
correct diabetes. All they understood was the victims had an intense thirst, enormous 
urine output, and wasting away of the body that slowly expired. Children with the 
disease died quickly and older folks struggled with devastating complications. 
Aretaeus of Cappadocia (in the second century A.D.) was one of the firsts to provide 
a fairly complete clinical description of diabetes. He was the man who coined the 
term diabetes which means "going through" or "siphon", the literal translation which 
reflects the early understanding of this disease that drained patients off more fluid 
than they could consume (Morton, 1970; Sonksen, 1984). Later, in the 17'~ century, 
the Latin word for honey-"mellitus" was appended to diabetes for its link with 
sweet urine, which was observed at a much earlier time (Sonksen, 1984). This 
disease was also mentioned by other ancient physicians such as Sushrut, Charak, 
Celsus, Galen, Demetius of Apamea, Caelius Aurelianus, Paul of Aegina, Aetius, 
Rhazea, Avicenna, and Haly Abbas (Gordon, 1959; Goldfine & Youngren, 1998). 
In the early days, treatment for diabetes ranged from herbs to "cataplasms to the 
hypochondrium over the kidneys" and even venesection (Gordon, 1959; 
MacCracken & Hoel, 1997). Emetics, purgatives, astringents, and refrigerant 
remedies were also prescribed. Engaging in exercise was encouraged, preferably on 
horseback to "employ moderate friction" and alleviate excess urination (Gordon, 
1959). For more than two millennia, diabetes was thought to be a disease of the 
kidney and bladder. Therefore, remedies prescribed were mostly for combating 
polyuria. According to Traditional Chinese Medicine, the Chinese believed that 
improper diet such as indulgence in alcohol and intemperance in sexual life was the 
main cause of this disease (Chen, 1994). Hence, avoidance of sex and wine were 
also prescribed. There were also those who practised bleeding, blistering, doping 
with opium, and overfeeding to compensate the loss of fluid and weight (Bliss, 1982 
cited in MacCracken & Hoel, 1997). Some tried strict meat diet and others tried a 
diet high in fat, which did more harms than good. Frederick Allen's starvation 
approach, although seems to be radical and cruel had the best result and allowed a 
number of young people to survive and became the first insulin users (Bliss, 1982 
cited in MacCracken & Hoel, 1997). 
The important milestone in understanding this disease occurred in the 191h century, 
with the discovery of islets of Langerhans by Paul Langerhans in 1869 and the 
observation by Minkowski and von Mering that removing the pancreas leads to 
diabetes. With further research by Banting, Best, Macleod, Collip, and many others, 
we have come to understand the cause of diabetes and the link between this disease 
with insulin (Morton, 1970; Goldfine & Youngren, 1998). Today, we know that 
diabetes means just one thing--a high blood sugar level. 
Appropriate dietary planning and regular physical exercise is the initial therapy for 
type 2 diabetes patients. According to Bell & Ovalle (2000), 5-10% reduction in 
body weight will lower insulin resistance. Decrease in calorie intake without 
significant weight loss will likewise decrease insulin resistance, as well as a low fat 
diet. Walking at least 40 minutes, four times weekly, is enough to enhanced insulin 
sensitivity. 6% reduction in the chance of developing diabetes has been shown with 
every 5 miles per week walk. And an even greater reduction in those at higher risk, 
i.e. with family history of diabetes and those that are obese. 
When the response is insufficient, the next step is appropriate pharmacotherapy, 
with the aim of a safe glycaemic control. Current pharmacological agent offers a 
wide range of selection to reduce hyperglycaemia. Generally, they can be 
categorised into five groups with different mode of action, namely biguanides, 
sulfonylureas, thiazolidinediones, alpha-glucosidase inhibitors, and meglitinides, 
used either alone or in combination. When oral therapy too failed, patients usually 
switched to insulin injection, with or without oral agent to improve insulin action 
(Leiter, 1999; Rajan, 1999; Gilmet, 1999; Cara, 1999; Bell & Ovalle, 2000; 
Edelman & Henry, 2001). With the advance in medical science, pancreatic beta cells 
transplant especially for type 1 diabetes sufferers is also possible (Lacy, 1995; 
Davalli et al., 2000; Stevens et al., 2001). 
However, there had been alarming reports on the adverse effects of these modern 
treatments. In the treatment of type 1 diabetes, pancreas transplant patients may 
suffer spontaneous hypoglycaemia (Battezzati et al., 1998). While those with insulin 
therapy should be aware of the possibilities of increase amount and distribution of 
